Form 8-K - Current report:
SEC Accession No. 0000950170-25-078340
Filing Date
2025-05-28
Accepted
2025-05-28 16:14:23
Documents
12
Period of Report
2025-05-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K revb-20250523.htm   iXBRL 8-K 55306
2 EX-99.1 revb-ex99_1.htm EX-99.1 20384
3 GRAPHIC img220778470_0.jpg GRAPHIC 18521
  Complete submission text file 0000950170-25-078340.txt   249105

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20250523.xsd EX-101.SCH 47760
14 EXTRACTED XBRL INSTANCE DOCUMENT revb-20250523_htm.xml XML 6769
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 25995565
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)